The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study

Although the accurate diagnosis of GDM before 24 weeks remains an ongoing discussion, dynamically assessed glucose concentrations during an early OGTT were closely associated with impaired glucose homeostasis and showed good predictive accuracy for later development of GDM as well as the requirement for insulin. These findings may be used to develop a protocol to distinguish between low- and high-risk mothers. Trial registration ClinicalTrials.gov NCT02035059.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2025-08-16
DOI
https://doi.org/10.1007/s00125-025-06517-0
Citations
4
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
8.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study

Heidi Jaksch‐Bogensperger, Eva Dölzlmüller, Evelyn A. Huhn, Lenka Vokálová et al.
4 citations
Diabetologia
Gestational Diabetes Research and Management
8.23
article

The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study

Heidi Jaksch‐Bogensperger, Eva Dölzlmüller, Evelyn A. Huhn, Lenka Vokálová, Daniel Eppel, Grammata Kotzaeridi, Bettina Winzeler, Günther Schäfer, Andrea Tura, Nicole Ochsenbein‐Kölble, Shane Vontelin van Breda, Christian Göbl, Anne Richter, Elke Bäz, Irène Hoesli, Mirjam Kunze, Thorsten Fischer, M Todesco Bernasconi, Laura Weidinger, Helena Stach
article en
4 citations

Abstract

Although the accurate diagnosis of GDM before 24 weeks remains an ongoing discussion, dynamically assessed glucose concentrations during an early OGTT were closely associated with impaired glucose homeostasis and showed good predictive accuracy for later development of GDM as well as the requirement for insulin. These findings may be used to develop a protocol to distinguish between low- and high-risk mothers. Trial registration ClinicalTrials.gov NCT02035059.

DiabetologiaVol. 68(11)
Universität Hamburg (DE), Paracelsus Medical University (AT), University Hospital of Bern (CH), University Medical Center Freiburg (DE), University Hospital of Basel (CH), Hospital Base (CL), University Hospital of Zurich (CH), University Medical Center Hamburg-Eppendorf (DE), Neuroscience Institute (IT), Salzburger Landeskliniken (AT), Kantonsspital Aarau (CH), Medical University of Vienna (AT)
Universität Basel, Universität Wien, Medizinische Universität Wien, European Association for the Study of Diabetes, Universitätsspital Zürich
Openalex Percentile: Top 2%
Gestational Diabetes Research and Management
8.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.